Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Protocol For A Phase II Double-Blind, Placebo-Controlled, Randomized Study Of Celecoxib (Sc-58635) In Oral Premalignant Lesions, Investigator IND

NCT00036283 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00036283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Protocol For A Phase II Double-Blind, Placebo-Controlled, Randomized Study Of Celecoxib (Sc-58635) In Oral Premalignant Lesions, Investigator IND
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2000
Completion date
April 30, 2004
Enrollment
42
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

precancerous conditions